Login to Your Account

Going to the Source

Engineering Stem Cells for Lasting Melanoma Vaccine

By Anette Breindl
Science Editor

Monday, December 5, 2011
Researchers at the University of California, Los Angeles, reported last week that they have been able to induce long-lasting T-cell responses to melanoma cells by engineering not the T cells themselves, but their progenitor cells.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription